CSH guidelines for the diagnosis and treatment of drug-induced liver injury

被引:4
作者
Yue-cheng Yu
Yi-min Mao
Cheng-wei Chen
Jin-jun Chen
Jun Chen
Wen-ming Cong
Yang Ding
Zhong-ping Duan
Qing-chun Fu
Xiao-yan Guo
Peng Hu
Xi-qi Hu
Ji-dong Jia
Rong-tao Lai
Dong-liang Li
Ying-xia Liu
Lun-gen Lu
Shi-wu Ma
Xiong Ma
Yue-min Nan
Hong Ren
Tao Shen
Hao Wang
Ji-yao Wang
Tai-ling Wang
Xiao-jin Wang
Lai Wei
Qing Xie
Wen Xie
Chang-qing Yang
Dong-liang Yang
Yan-yan Yu
Min-de Zeng
Li Zhang
Xin-yan Zhao
Hui Zhuang
机构
[1] Nanjing University of Chinese Medicine,Liver Disease Center of PLA, Bayi Hospital
[2] Shanghai Jiaotong University,Department of Gastroenterology, Renji Hospital, School of Medicine
[3] Nanjing Military Command,Shanghai Liver Diseases Research Center, 85th Hospital
[4] Southern Medical University,Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital
[5] Central South University,Liver Diseases Center, Second Xiangya Hospital
[6] Second Military Medical University,Department of Pathology, Eastern Hepatobiliary Surgery Hospital
[7] Shengjing Hospital of China Medical University,Department of Infectious Disease
[8] Capital Medical University,Artificial Liver Center, Beijing Youan Hospital
[9] Xi’an Jiaotong University,Department of Gastroenterology, Second Affiliated Hospital
[10] Chongqing Medical University,Department of Infectious Diseases, Institute for Viral Hepatitis, Second Affiliated Hospital
[11] Fudan University,Department of Pathology, School of Medicine
[12] Capital Medial University,Liver Research Center, Beijing Friendship Hospital
[13] Shanghai Jiaotong University,Department of Infectious Diseases, Ruijin Hospital, School of Medicine
[14] Fuzhou General Hospital of PLA,Department of Hepatobiliary Disease
[15] Shenzhen Third People’s Hospital,Department of Liver Disease
[16] Shanghai Jiaotong University,Department of Gastroenterology, Shanghai First People’s Hospital, School of Medicine
[17] Kunming General Hospital of PLA,Department of Infectious Diseases
[18] Hebei Medical University,Department of Traditional and Western Medical Hepatology, Third Affiliated Hospital
[19] Beijing University,Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences
[20] Beijing University,Institute of Hepatology, People’s Hospital
[21] Fudan University,Department of Gastroenterology, Zhongshan Hospital, School of Medicine
[22] Capital Medical University,Department of Pathology, China
[23] Capital Medical University,Japan Friendship Hospital
[24] Tongji University,Center of Liver Diseases, Beijing Ditan Hospital
[25] Huazhong University of Science and Technology,Department of Gastroenterology, Tongji Hospital, School of Medicine
[26] Beijing University First Hospital,Department of Infectious Disease, Union Hospital, Tongji Medical College
[27] Beijing University of Chinese Medicine,Department of Infectious Disease
来源
Hepatology International | 2017年 / 11卷
关键词
Drug-induced liver injury; Epidemiology; Pathogenesis; Pathology; Clinical type; Diagnosis; Differential diagnosis; Treatment; Prevention; Recommendations;
D O I
暂无
中图分类号
学科分类号
摘要
Drug-induced liver injury (DILI) is an important clinical problem, which has received more attention in recent decades. It can be induced by small chemical molecules, biological agents, traditional Chinese medicines (TCM), natural medicines (NM), health products (HP), and dietary supplements (DS). Idiosyncratic DILI is far more common than intrinsic DILI clinically and can be classified into hepatocellular injury, cholestatic injury, hepatocellular-cholestatic mixed injury, and vascular injury based on the types of injured target cells. The CSH guidelines summarized the epidemiology, pathogenesis, pathology, and clinical manifestation and gives 16 evidence-based recommendations on diagnosis, differential diagnosis, treatment, and prevention of DILI.
引用
收藏
页码:221 / 241
页数:20
相关论文
共 304 条
[51]  
Azizi F(2010)The role of cytokines in the mechanism of adverse drug reactions Nat Rev Mol Cell Biol 11 700-329
[52]  
Amouzegar A(2013)Immunoallergic drug-induced liver injury in humans Semin Liver Dis 33 321-928
[53]  
Martinez MA(2014)Molecular mechanisms of necroptosis: an ordered cellular explosion Gastroenterology 146 914-81
[54]  
Vuppalanchi R(2014)The unfolded protein response in fatty liver disease Expert Opin Drug Saf 13 67-115
[55]  
Fontana RJ(2012)Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives Drug Metab Rev 44 107-976
[56]  
Saadi T(2011)Idiosyncratic drug-induced liver injury: an update on the 2007 overview Dig Dis Sci 56 958-2259
[57]  
Waterman M(2010)Role of immune reactions in drug-induced liver injury (DILI) Gastroenterology 138 2246-556
[58]  
Yassin H(2011)Drug-induced autoimmune-like hepatitis Exp Biol Med 236 546-393
[59]  
Soriano V(2010)Risk factors for idiosyncratic drug-induced liver injury Front Med China 4 385-897
[60]  
Puoti M(2011)The emerging role of autophagy in alcoholic liver disease Dev Comp Immunol 35 886-499